A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts.

MLA

Ghesquières, Hervé, et al. “A Susceptibility Locus for Classical Hodgkin Lymphoma at 8q24 near MYC/PVT1 Predicts Patient Outcome in Two Independent Cohorts.” British Journal of Haematology, vol. 180, no. 2, Jan. 2018, pp. 286–90. EBSCOhost, https://doi.org/10.1111/bjh.14306.

APA

Ghesquières, H., Larrabee, B. R., Casasnovas, O., Maurer, M. J., McKay, J. D., Ansell, S. M., Montgomery, D., Asmann, Y. W., Farrell, K., Verney, A., Slager, S. L., Allmer, C., Perrot, A., Delarue, R., Habermann, T. M., Dupuis, J., Link, B. K., Canioni, D., Dogan, A., … Salles, G. (2018). A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts. British Journal of Haematology, 180(2), 286–290. https://doi.org/10.1111/bjh.14306

Chicago

Ghesquières, Hervé, Beth R Larrabee, Olivier Casasnovas, Matthew J Maurer, James D McKay, Stephen M Ansell, Dorothy Montgomery, et al. 2018. “A Susceptibility Locus for Classical Hodgkin Lymphoma at 8q24 near MYC/PVT1 Predicts Patient Outcome in Two Independent Cohorts.” British Journal of Haematology 180 (2): 286–90. doi:10.1111/bjh.14306.